STRO
Sutro BiopharmaNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$477.23M
P/E Ratio
—
EPS
$-16.35
Beta
1.55
52W High
$43.85
52W Low
$6.74
50-Day MA
$31.49
200-Day MA
$17.64
Dividend Yield
—
Profit Margin
-154.20%
Forward P/E
10.03
PEG Ratio
—
About Sutro Biopharma
Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $99.61M |
| Gross Profit (TTM) | $-65.33M |
| EBITDA | $-80.39M |
| Operating Margin | -203.90% |
| Return on Equity | -1810.00% |
| Return on Assets | -19.30% |
| Revenue/Share (TTM) | $10.29 |
| Book Value | $-4.04 |
| Price-to-Book | 2.11 |
| Price-to-Sales (TTM) | 4.79 |
| EV/Revenue | 2.909 |
| EV/EBITDA | 41.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -16.50% |
| Shares Outstanding | $16.57M |
| Float | $10.30M |
| % Insiders | 2.26% |
| % Institutions | 86.54% |
Historical Volatility
HV 10-Day
122.73%
HV 20-Day
124.34%
HV 30-Day
107.71%
HV 60-Day
90.73%
HV Rank
87.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($48.31 target)
2
Strong Buy9
Buy1
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026